298 related articles for article (PubMed ID: 32200566)
1. Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine.
Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson SA
Med J Aust; 2020 Apr; 212(7):321-327. PubMed ID: 32200566
[TBL] [Abstract][Full Text] [Related]
2. The impact of codeine re-scheduling on misuse: a retrospective review of calls to Australia's largest poisons centre.
Cairns R; Brown JA; Buckley NA
Addiction; 2016 Oct; 111(10):1848-53. PubMed ID: 27177599
[TBL] [Abstract][Full Text] [Related]
3. Community pharmacy naloxone supply, before and after rescheduling as an over-the-counter drug: sales and prescriptions data, 2014-2018.
Tse WC; Sanfilippo P; Lam T; Dietze P; Nielsen S
Med J Aust; 2020 Apr; 212(7):314-320. PubMed ID: 32124984
[TBL] [Abstract][Full Text] [Related]
4. An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia.
Gisev N; Nielsen S; Cama E; Larance B; Bruno R; Degenhardt L
Eur J Clin Pharmacol; 2016 Apr; 72(4):469-94. PubMed ID: 26690771
[TBL] [Abstract][Full Text] [Related]
5. The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis.
Boone CG; Antoniou T; Juurlink DN; von den Baumen TR; Kitchen SA; Richards GC; Tadrous M; Gomes T
CMAJ Open; 2021; 9(4):E1181-E1186. PubMed ID: 34906994
[TBL] [Abstract][Full Text] [Related]
6. Use of analgesics following rescheduling of codeine in Australia: An interrupted time series analysis in the veteran population.
Kalisch Ellett LM; Kemp-Casey A; Kassie GM; Pratt NL; Roughead EE
Int J Drug Policy; 2020 Jul; 81():102767. PubMed ID: 32416524
[TBL] [Abstract][Full Text] [Related]
7. Supply of codeine combination analgesics from Australian pharmacies in the context of voluntary real-time recording and regulatory change: A simulated patient study.
Collins JC; Hillman JM; Schneider CR; Moles RJ
Int J Drug Policy; 2019 Dec; 74():216-222. PubMed ID: 31677483
[TBL] [Abstract][Full Text] [Related]
8. Misuse of non-prescription codeine containing products: Recommendations for detection and reduction of risk in community pharmacies.
Van Hout MC; Norman I
Int J Drug Policy; 2016 Jan; 27():17-22. PubMed ID: 26454626
[TBL] [Abstract][Full Text] [Related]
9. Codeine use and harms in Australia: evaluating the effects of re-scheduling.
Cairns R; Schaffer AL; Brown JA; Pearson SA; Buckley NA
Addiction; 2020 Mar; 115(3):451-459. PubMed ID: 31577369
[TBL] [Abstract][Full Text] [Related]
10. A wastewater-based evaluation of the effectiveness of codeine control measures in Australia.
Tscharke BJ; O'Brien JW; Ahmed F; Nguyen L; Ghetia M; Chan G; Thai P; Gerber C; Bade R; Mueller J; Thomas KV; White J; Hall W
Addiction; 2023 Mar; 118(3):480-488. PubMed ID: 36367203
[TBL] [Abstract][Full Text] [Related]
11. Over-the-Counter Codeine-from Therapeutic Use to Dependence, and the Grey Areas in Between.
Nielsen S; Van Hout MC
Curr Top Behav Neurosci; 2017; 34():59-75. PubMed ID: 26768736
[TBL] [Abstract][Full Text] [Related]
12. Opportunities and challenges: over-the-counter codeine supply from the codeine consumer's perspective.
Nielsen S; Cameron J; Pahoki S
Int J Pharm Pract; 2013 Jun; 21(3):161-8. PubMed ID: 23419000
[TBL] [Abstract][Full Text] [Related]
13. Changes in Australian prescription opioid use following codeine rescheduling: A retrospective study using pharmaceutical benefits data.
Middleton M; Nielsen S
Int J Drug Policy; 2019 Dec; 74():170-173. PubMed ID: 31622949
[TBL] [Abstract][Full Text] [Related]
14. An investigation of prescription and over-the-counter supply of ophthalmic chloramphenicol in Wales in the 5 years following reclassification.
Du HC; John DN; Walker R
Int J Pharm Pract; 2014 Feb; 22(1):20-7. PubMed ID: 23590558
[TBL] [Abstract][Full Text] [Related]
15. The views of Australian adults experiencing pain on the upscheduling of codeine-containing analgesics to 'prescription only'.
Mishriky J; Stupans I; Chan V
Int J Clin Pharm; 2021 Apr; 43(2):386-393. PubMed ID: 32301065
[TBL] [Abstract][Full Text] [Related]
16. Over-the-counter codeine use in Iceland: the impact of increased access.
Almarsdóttir AB; Grimsson A
Scand J Public Health; 2000 Dec; 28(4):270-4. PubMed ID: 11228114
[TBL] [Abstract][Full Text] [Related]
17. Codeine consumption from over-the-counter anti-cough syrup in Taiwan: A useful indicator for opioid abuse.
Lo MY; Ong MW; Lin JG; Sun WZ
Acta Anaesthesiol Taiwan; 2015 Dec; 53(4):135-8. PubMed ID: 26646544
[TBL] [Abstract][Full Text] [Related]
18. How well are national guidelines relating to the general sales of aspirin and paracetamol, adhered to by retail stores: a mystery shopper study.
Molloy P; Chambers R; Cork T
BMJ Open; 2016 Jan; 6(1):e010081. PubMed ID: 26781508
[TBL] [Abstract][Full Text] [Related]
19. The extent and correlates of community-based pharmaceutical opioid utilisation in Australia.
Degenhardt L; Gisev N; Cama E; Nielsen S; Larance B; Bruno R
Pharmacoepidemiol Drug Saf; 2016 May; 25(5):521-38. PubMed ID: 26781123
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional analysis of over-the-counter codeine use among an Australian sample of people who regularly inject drugs.
Arora S; Roxburgh A; Bruno R; Nielsen S; Burns L
Drug Alcohol Rev; 2013 Nov; 32(6):574-81. PubMed ID: 23751176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
